Overexpression of SPHK1 and the resulting production of S1P correlated with malignancy, poor prognosis, and shorter survival time in different types of gliomas, especially GBMs (Young and Van Brocklyn, 2007; Li et al., 2022). The gene discussed is SPHK1; the disease is central nervous system cancer.